Lilly Announces Second Positive Phase III Gastric Cancer Study
INDIANAPOLIS, Sept. 26, 2013 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced top-line results from two global Phase III studies... Read More
For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org
Together, we will defeat stomach cancer.
Together, we will defeat stomach cancer.
MORE INFODONATE